Real-World test: can a popular Weight-Loss drug deliver lasting results?
NCT ID NCT07081178
Summary
This study is observing 555 adults with obesity in Germany who are already prescribed the medication semaglutide (Wegovy) by their doctor. The goal is to collect real-world data over 12 months on how well the drug, combined with lifestyle changes, helps people lose weight and improve related health measures like blood sugar and cholesterol. Participants have already decided to take the medication; the study is simply tracking their results in everyday practice.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medizinisches Versorgungszentrum Am Bahnhof Spandau GbR
Berlin, 13597, Germany
Conditions
Explore the condition pages connected to this study.